The life sciences sector is a significant contributor to the UK economy. In the UK, there are important valuable tax issues for this sector to support the financing of medical research, as well as the development, protection and exploitation of intellectual property (IP). Advisers supporting clients in the life sciences sector should also review the international structure of their business arrangements to ensure it is BEPS compliant. In view of the recent reduction in the lifetime limit for what was entrepreneurs’ relief, consideration should also be given to any future exit plans.
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes:
The life sciences sector is a significant contributor to the UK economy. In the UK, there are important valuable tax issues for this sector to support the financing of medical research, as well as the development, protection and exploitation of intellectual property (IP). Advisers supporting clients in the life sciences sector should also review the international structure of their business arrangements to ensure it is BEPS compliant. In view of the recent reduction in the lifetime limit for what was entrepreneurs’ relief, consideration should also be given to any future exit plans.
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes:
